Skip to main content

Accelr8, Denver Health Get $2M Grant for Infections Dx Project

NEW YORK (GenomeWeb News) – Accelr8 Technology and integrated healthcare provider Denver Health have received a $2 million award from the Defense Medical Research and Development Program to develop diagnostic products for antibiotic-resistant infections.

Accelr8 said today that the collaboration will apply the firm's BACcel system to wound infections and other serious infections secondary to trauma. It said that the joint project was the sole recipient under the Military Infectious Diseases Applied Research Award program for rapid detection of serious antibiotic-resistant infections.

In addition to Accelr8 and Denver Health, other collaborators in the effort include the Department of Veterans Affairs Eastern Colorado Healthcare System, the Washington Hospital Center, and Creighton University School of Medicine.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.